IR
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Disclosure
Total of 10posts
| Number | Title | Person with Duty to Submit | Receipt Date |
|---|---|---|---|
| 10 | Additional Listing(유상증자(구주주배정)) | KOSDAQ STOCK MKT. | 2025-07-02 |
| 9 | Results of issuance(Voluntary Disclosure) | 2025-06-24 | |
| 8 | Results of Subscription (Voluntary Disclosure) | 2025-06-23 | |
| 7 | Results of Subscription (Voluntary Disclosure) | 2025-06-18 | |
| 6 | Extension of overheated short-selling issue designation (subject to extension of restriction on short-selling) | KOSDAQ STOCK MKT. | 2025-06-13 |
| 5 | Release from designation as Investment Alert Issue & Prior notice on Re-designation | 2025-06-12 | |
| 4 | Designation of overheated short-selling issues (applied by a restriction on short-selling) | KOSDAQ STOCK MKT. | 2025-06-12 |
| 3 | [Revised]Decision on Paid-in Capital Increase(주주배정후 실권주 일반공모) | 2025-06-12 | |
| 2 | Final Issue Price of Rights Offering | 2025-06-12 | |
| 1 | Lawsuit (Charging More Than Certain Amount) | 2025-06-09 |
